Detalhe da pesquisa
1.
Time to Disability Milestones and Annualized Relapse Rates in NMOSD and MOGAD.
Ann Neurol
; 95(4): 720-732, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38086777
2.
"So at least now I know how to deal with things myself, what I can do if it gets really bad again"-experiences with a long-term cross-sectoral advocacy care and case management for severe multiple sclerosis: a qualitative study.
BMC Health Serv Res
; 24(1): 453, 2024 Apr 10.
Artigo
Inglês
| MEDLINE | ID: mdl-38600493
3.
Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity.
Proc Natl Acad Sci U S A
; 118(1)2021 01 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33376202
4.
Cerebrospinal Fluid Analysis Post-COVID-19 Is Not Suggestive of Persistent Central Nervous System Infection.
Ann Neurol
; 91(1): 150-157, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34724243
5.
Association of cerebrospinal fluid brain-binding autoantibodies with cognitive impairment in post-COVID-19 syndrome.
Brain Behav Immun
; 109: 139-143, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36657623
6.
Cognition in patients with neuromyelitis optica spectrum disorders: A prospective multicentre study of 217 patients (CogniNMO-Study).
Mult Scler
; 29(7): 819-831, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-36786424
7.
Cultural adaptation of the Integrated Palliative care Outcome Scale for neurological symptoms.
Palliat Support Care
; : 1-10, 2023 Apr 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37039454
8.
Time to diagnosis in multiple sclerosis: Epidemiological data from the German Multiple Sclerosis Registry.
Mult Scler
; 28(6): 865-871, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-34449299
9.
Neuro-COVID-19 is more than anosmia: clinical presentation, neurodiagnostics, therapies, and prognosis.
Curr Opin Neurol
; 34(3): 423-431, 2021 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33709973
10.
Pharmacovigilance during treatment of multiple sclerosis: early recognition of CNS complications.
J Neurol Neurosurg Psychiatry
; 92(2): 177-188, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33229453
11.
High-intensity interval training reduces neutrophil-to-lymphocyte ratio in persons with multiple sclerosis during inpatient rehabilitation.
Mult Scler
; 27(7): 1136-1139, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32880214
12.
Neurological symptoms and complications in predominantly hospitalized COVID-19 patients: Results of the European multinational Lean European Open Survey on SARS-Infected Patients (LEOSS).
Eur J Neurol
; 28(12): 3925-3937, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34411383
13.
[Dysphagia in Multiple Sclerosis - an underestimated symptom?] / Dysphagie bei Multipler Sklerose ein unterschätztes Symptom?
Fortschr Neurol Psychiatr
; 89(4): 168-177, 2021 Apr.
Artigo
Alemão
| MEDLINE | ID: mdl-33571999
14.
[Toxicity after chimeric antigen receptor T-cell therapy : Overview and management of early and late onset side effects]. / Toxizitäten nach Chimärer-Antigenrezeptor-T-Zell-Therapie : Übersicht und Management früher und verzögerter Nebenwirkungen.
Internist (Berl)
; 62(6): 611-619, 2021 Jun.
Artigo
Alemão
| MEDLINE | ID: mdl-34032877
15.
Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 91(7): 681-686, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32371533
16.
Age and the risks of high-efficacy disease modifying drugs in multiple sclerosis.
Curr Opin Neurol
; 32(3): 305-312, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-30985373
17.
Performance of PML diagnostic criteria in natalizumab-associated PML: data from the Dutch-Belgian cohort.
J Neurol Neurosurg Psychiatry
; 90(1): 44-46, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30100552
18.
Influence of combined functional resistance and endurance exercise over 12 weeks on matrix metalloproteinase-2 serum concentration in persons with relapsing-remitting multiple sclerosis - a community-based randomized controlled trial.
BMC Neurol
; 19(1): 314, 2019 Dec 06.
Artigo
Inglês
| MEDLINE | ID: mdl-31810462
19.
[Diagnostics and treatment of tuberculosis under immunotherapy for multiple sclerosis : Current status and recommendations in Germany]. / Diagnostik und Therapie von Tuberkulose unter Immuntherapien für Multiple Sklerose : Aktueller Stand und Empfehlungen in Deutschland.
Nervenarzt
; 90(12): 1245-1253, 2019 Dec.
Artigo
Alemão
| MEDLINE | ID: mdl-31297574
20.
Inflammatory natalizumab-associated PML: baseline characteristics, lesion evolution and relation with PML-IRIS.
J Neurol Neurosurg Psychiatry
; 89(5): 535-541, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29142146